Elevated matrix metalloproteinase-3 level may affect hearing function in patients with rheumatoid arthritis.

Background: Rheumatoid arthritis (RA) is an autoimmune disease. Sensorineural and conductive hearing loss have been reported in RA, but the results of most studies are not in agreement. The pathogenesis of the hearing loss is not clearly understood.